# Holiferm

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/holiferm

- Industry: Biotechnology
- Headquarters: Birkenhead, UK
- Website: www.holiferm.com
- Total disclosed funding: $24M
- Latest round: Series B (Sep 16, 2026)
- Investors on record: 7

## About

Holiferm Limited, based in the United Kingdom, develops innovative biosurfactants derived from renewable materials, offering sustainable alternatives for various industries including personal care and household cleaning. Holiferm Limited specializes in producing biosurfactants, primarily sophorolipid biosurfactants. The company was founded in 2018 in Manchester, UK, by Ben Dolman and James Winterburn. In September 2026, Holiferm Limited raised an undisclosed amount of series B funding led by RA Capital Management, with participation from Thai Oil Group, Rivas Capital, Merseyside Pension Fund, Clean Growth Investment Management, Rhapsody Venture Partners, and ICOS Capital. Holiferm specializes in the production of biosurfactants, focusing on its flagship line of sophorolipid biosurfactants. These products are derived from renewable materials through advanced fermentation processes, designed to serve as environmentally friendly alternatives to traditional petrochemical-derived ingredients. The core offerings target various application areas, such as personal care, household cleaning, and industrial uses. Holiferm's products are being increasingly adopted by distributors and manufacturers prioritizing sustainability, indicating a strong demand within the eco-friendly market across Europe and the United States.Holiferm generates revenue through direct sales and strategic partnerships with distributors and product manufacturers. The company operates primarily on a B2B model, supplying biosurfactants to various industrial clients who incorporate these ingredients into their formulations. Their pricing is structured around volume-based agreements, providing incentives for bulk purchases. The sophorolipid biosurfactants are positioned as premium, sustainable alternatives, aligning with the market's increasing demand for eco-friendly ingredients, thus facilitating consistent revenue streams as Holiferm expands its offerings and collaborations. The company will use the September 2026 funding to support its development of sustainable biosurfactants that replace harmful petrochemicals in everyday detergents.

## Funding rounds

- Series B, Sep 16, 2026 — Merseyside Pension Fund, ICOS Capital, RA Capital Management, Rivas Capital, Rhapsody Venture Partners, Clean Growth Investment Management, Thai Oil Group
- Series B, Sep 19, 2023, $22M — Rhapsody Venture Partners, Clean Growth Investment Management
- Series A, Feb 19, 2019, $1.3M — ICOS Capital

## Investors

- ICOS Capital (https://capitalatlas.ai/funds/icos-capital) — Series A, Series B
- Rhapsody Venture Partners (https://capitalatlas.ai/funds/rhapsody-venture-partners) — Series B
- Clean Growth Investment Management (https://capitalatlas.ai/funds/clean-growth-investment-management) — Series B
- Merseyside Pension Fund — Series B
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series B
- Rivas Capital — Series B
- Thai Oil Group — Series B